144 related articles for article (PubMed ID: 36116708)
1. Anti-metastatic effects of 1,2,3,4,6-Penta-O-galloyl-β-D-glucose in colorectal cancer: Regulation of cathepsin B-mediated extracellular matrix dynamics and epithelial-to-mesenchymal transition.
Yang H; Yue GG; Leung PC; Wong CK; Zhang YJ; Lau CB
Pharmacol Res; 2022 Oct; 184():106457. PubMed ID: 36116708
[TBL] [Abstract][Full Text] [Related]
2. Penta-O-galloyl-β-D-glucose ameliorates inflammation by inhibiting MyD88/NF-κB and MyD88/MAPK signalling pathways.
Jang SE; Hyam SR; Jeong JJ; Han MJ; Kim DH
Br J Pharmacol; 2013 Nov; 170(5):1078-91. PubMed ID: 23941302
[TBL] [Abstract][Full Text] [Related]
3. 1,2,3,4,6-Penta-O-galloyl-β-d-glucose suppresses colon cancer through induction of tumor suppressor.
Kawk SH; Kang YR; Kim YH
Bioorg Med Chem Lett; 2018 Jul; 28(12):2117-2123. PubMed ID: 29778287
[TBL] [Abstract][Full Text] [Related]
4. Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo.
Hu H; Lee HJ; Jiang C; Zhang J; Wang L; Zhao Y; Xiang Q; Lee EO; Kim SH; Lü J
Mol Cancer Ther; 2008 Sep; 7(9):2681-91. PubMed ID: 18790750
[TBL] [Abstract][Full Text] [Related]
5. Analgesic effects of 1,2,3,4,6-penta-O-galloyl-β-D-glucose in an animal model of lipopolysaccharide-induced pain.
Chun K; Kim SO; Lee SH
Int J Mol Med; 2016 Oct; 38(4):1264-70. PubMed ID: 27600119
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic insights into the anti-tumor and anti-metastatic effects of Patrinia villosa aqueous extract in colon cancer via modulation of TGF-β R1-smad2/3-E-cadherin and FAK-RhoA-cofilin pathways.
Yang H; Yue GG; Yuen KK; Gao S; Leung PC; Wong CK; Lau CB
Phytomedicine; 2023 Aug; 117():154900. PubMed ID: 37269754
[TBL] [Abstract][Full Text] [Related]
7. 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose increases a population of T regulatory cells and inhibits IgE production in ovalbumin-sensitized mice.
Kim YH; Yang X; Yamashita S; Kumazoe M; Huang Y; Nakahara K; Won YS; Murata M; Lin IC; Tachibana H
Int Immunopharmacol; 2015 May; 26(1):30-6. PubMed ID: 25737197
[TBL] [Abstract][Full Text] [Related]
8. In vitro study of anti-ER positive breast cancer effect and mechanism of 1,2,3,4-6-pentyl-O-galloyl-beta-d-glucose (PGG).
Xiang Q; Tang J; Luo Q; Xue J; Tao Y; Jiang H; Tian J; Fan C
Biomed Pharmacother; 2019 Mar; 111():813-820. PubMed ID: 30616080
[TBL] [Abstract][Full Text] [Related]
9. Penta-O-galloyl-beta-D-glucose inhibits phorbol myristate acetate-induced interleukin-8 [correction of intereukin-8] gene expression in human monocytic U937 cells through its inactivation of nuclear factor-kappaB.
Oh GS; Pae HO; Choi BM; Lee HS; Kim IK; Yun YG; Kim JD; Chung HT
Int Immunopharmacol; 2004 Mar; 4(3):377-86. PubMed ID: 15037215
[TBL] [Abstract][Full Text] [Related]
10. Vasodilatory and anti-inflammatory effects of the 1,2,3,4,6-penta-O-galloyl-beta-D-glucose (PGG) via a nitric oxide-cGMP pathway.
Kang DG; Moon MK; Choi DH; Lee JK; Kwon TO; Lee HS
Eur J Pharmacol; 2005 Nov; 524(1-3):111-9. PubMed ID: 16253226
[TBL] [Abstract][Full Text] [Related]
11. Anti-cancer gallotannin penta-O-galloyl-beta-D-glucose is a nanomolar inhibitor of select mammalian DNA polymerases.
Mizushina Y; Zhang J; Pugliese A; Kim SH; Lü J
Biochem Pharmacol; 2010 Oct; 80(8):1125-32. PubMed ID: 20599777
[TBL] [Abstract][Full Text] [Related]
12. Penta-O-galloyl-beta-D-glucose induces G1 arrest and DNA replicative S-phase arrest independently of cyclin-dependent kinase inhibitor 1A, cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple negative xenograft growth.
Chai Y; Lee HJ; Shaik AA; Nkhata K; Xing C; Zhang J; Jeong SJ; Kim SH; Lu J
Breast Cancer Res; 2010; 12(5):R67. PubMed ID: 20809980
[TBL] [Abstract][Full Text] [Related]
13. 1,2,3,4,6-Penta-O-galloyl-d-glucose Interrupts the Early Adipocyte Lifecycle and Attenuates Adiposity and Hepatic Steatosis in Mice with Diet-Induced Obesity.
Sathyanarayana AR; Lu CK; Liaw CC; Chang CC; Han HY; Green BD; Huang WJ; Huang C; He WD; Lee LC; Liu HK
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409415
[TBL] [Abstract][Full Text] [Related]
14. The hydrolyzable gallotannin, penta-O-galloyl-β-D-glucopyranoside, inhibits the formation of advanced glycation endproducts by protecting protein structure.
Ma H; Liu W; Frost L; Wang L; Kong L; Dain JA; Seeram NP
Mol Biosyst; 2015 May; 11(5):1338-47. PubMed ID: 25789915
[TBL] [Abstract][Full Text] [Related]
15. Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways.
Huh JE; Lee EO; Kim MS; Kang KS; Kim CH; Cha BC; Surh YJ; Kim SH
Carcinogenesis; 2005 Aug; 26(8):1436-45. PubMed ID: 15845650
[TBL] [Abstract][Full Text] [Related]
16. 1,2,3,4,6-Penta-O-galloly-beta-D-glucose suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1α and signaling in LNCaP prostate cancer cells.
Park KY; Lee HJ; Jeong SJ; Lee HJ; Kim HS; Kim SH; Lim S; Kim HC; Lü J; Kim SH
Biol Pharm Bull; 2010; 33(11):1835-40. PubMed ID: 21048308
[TBL] [Abstract][Full Text] [Related]
17. In vitro inhibition of fatty acid synthase by 1,2,3,4,6-penta-O-galloyl-β-D-glucose plays a vital role in anti-tumour activity.
Zhao W; Wang Y; Hao W; Zhao M; Peng S
Biochem Biophys Res Commun; 2014 Mar; 445(2):346-51. PubMed ID: 24508804
[TBL] [Abstract][Full Text] [Related]
18. Glucose- and Triglyceride-lowering Dietary Penta-O-galloyl-α-D-Glucose Reduces Expression of PPARγ and C/EBPα, Induces p21-Mediated G1 Phase Cell Cycle Arrest, and Inhibits Adipogenesis in 3T3-L1 Preadipocytes.
Liu X; Malki A; Cao Y; Li Y; Qian Y; Wang X; Chen X
Exp Clin Endocrinol Diabetes; 2015 May; 123(5):308-16. PubMed ID: 25988880
[TBL] [Abstract][Full Text] [Related]
19. Penta-O-galloyl-beta-D-glucose induces S- and G(1)-cell cycle arrests in prostate cancer cells targeting DNA replication and cyclin D1.
Hu H; Zhang J; Lee HJ; Kim SH; Lü J
Carcinogenesis; 2009 May; 30(5):818-23. PubMed ID: 19269999
[TBL] [Abstract][Full Text] [Related]
20. Penta-O-galloyl-β-D-glucose attenuates cisplatin-induced nephrotoxicity via reactive oxygen species reduction in renal epithelial cells and enhances antitumor activity in Caki-2 renal cancer cells.
Ryu HG; Jeong SJ; Kwon HY; Lee HJ; Lee EO; Lee MH; Choi SH; Ahn KS; Kim SH
Toxicol In Vitro; 2012 Mar; 26(2):206-14. PubMed ID: 22172427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
